Does the prophylactic use of Palivizumab in premature patients with Down Syndrome in respiratory syncytial virus infection reduce the hospitalization rate? An integrative review. RSD [Internet]. 2024 Jan. 29 [cited 2025 Jun. 28];13(1):e13513144288. Available from: https://ojs34.rsdjournal.org/index.php/rsd/article/view/44288